In the original article, the name of the author Rafal Farjo was misspelled as Rafal Fario.
The correct spelling appears above. The authors apologize for this error. This does not change the scientific conclusions of the article in any way.
The original article has been updated.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Summary
Keywords
leptin, ObR antagonist, peptide drug, VEGF, ocular neoangiogenesis
Citation
Coroniti R, Farjo R, Nuno DJ, Otvos L, Scolaro L and Surmacz E (2016) Corrigendum: Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models. Front. Mol. Biosci. 3:75. doi: 10.3389/fmolb.2016.00075
Received
26 October 2016
Accepted
31 October 2016
Published
18 November 2016
Volume
3 - 2016
Edited and reviewed by
Ali Tavassoli, University of Southampton, UK
Updates
Copyright
© 2016 Coroniti, Farjo, Nuno, Otvos, Scolaro and Surmacz.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Eva Surmacz surmacz@temple.edu
This article was submitted to Chemical Biology, a section of the journal Frontiers in Molecular Biosciences
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.